Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H van der Zee

Showing results (121-130 of 174) with videos related to

Pageof 18
Sort By:
Disability and Rehabilitation|March 1, 2012
Development and structural validation of a shortened version of the Participation ScaleS A M Stevelink, T Hoekstra, S M T Nardi, et al.
Dermatology (Basel, Switzerland)|February 3, 2021
Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis SuppurativaAllard R J V Vossen, Kelsey R van Straalen, Evi F H Swolfs, et al.
Frontiers in Immunology|October 10, 2022
Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?K R van Straalen, K Dudink, P Aarts, et al.
Journal of Rehabilitation Medicine|September 3, 2010
Reproducibility of three self-report participation measures: The ICF Measure of Participation and Activities Screener, the Participation Scale, and the Utrecht Scale for Evaluation of Rehabilitation-ParticipationCarlijn H van der Zee, Annique R Priesterbach, Luikje van der Dussen, et al.
The British Journal of Dermatology|August 19, 2016
Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional studyI C Janse, I E Deckers, A D van der Maten, et al.
The British Journal of Dermatology|October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trialPim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
The British Journal of Dermatology|June 22, 2019
The refined Hurley classification: the inter-rater and intrarater reliability and face validityL M Prens, A Rondags, R J Volkering, et al.
Dermatology and Therapy|June 29, 2025
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative ReviewFalk G Bechara, Angelo V Marzano, Antonio Martorell, et al.
Dermatology (Basel, Switzerland)|October 14, 2021
Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch CohortKoen Dudink, Pim Aarts, Christine B Ardon, et al.
Journal of the American Academy of Dermatology|August 9, 2020
Impact of hidradenitis suppurativa on work productivity and associated risk factorsKelsey R van Straalen, Lisette M Prens, Tjerk H Hylkema, et al.
Pageof 18

Showing results (121-130 of 174) with videos related to

Sort By:
Pageof 18
Disability and Rehabilitation|March 1, 2012
Development and structural validation of a shortened version of the Participation ScaleS A M Stevelink, T Hoekstra, S M T Nardi, et al.
Dermatology (Basel, Switzerland)|February 3, 2021
Nicotine Dependency and Readiness to Quit Smoking among Patients with Hidradenitis SuppurativaAllard R J V Vossen, Kelsey R van Straalen, Evi F H Swolfs, et al.
Frontiers in Immunology|October 10, 2022
Complement activation in Hidradenitis suppurativa: Covert low-grade inflammation or innocent bystander?K R van Straalen, K Dudink, P Aarts, et al.
Journal of Rehabilitation Medicine|September 3, 2010
Reproducibility of three self-report participation measures: The ICF Measure of Participation and Activities Screener, the Participation Scale, and the Utrecht Scale for Evaluation of Rehabilitation-ParticipationCarlijn H van der Zee, Annique R Priesterbach, Luikje van der Dussen, et al.
The British Journal of Dermatology|August 19, 2016
Sexual health and quality of life are impaired in hidradenitis suppurativa: a multicentre cross-sectional studyI C Janse, I E Deckers, A D van der Maten, et al.
The British Journal of Dermatology|October 15, 2025
Metformin in conjunction with doxycycline is not superior to doxycycline monotherapy for hidradenitis suppurativa; results of a phase III double-blinded randomized placebo- controlled trialPim Aarts, Nicole D K Koerts, Johanna C van Huijstee, et al.
The British Journal of Dermatology|June 22, 2019
The refined Hurley classification: the inter-rater and intrarater reliability and face validityL M Prens, A Rondags, R J Volkering, et al.
Dermatology and Therapy|June 29, 2025
Towards a Paradigm Shift in Delivering Hidradenitis Suppurativa Care: a Narrative ReviewFalk G Bechara, Angelo V Marzano, Antonio Martorell, et al.
Dermatology (Basel, Switzerland)|October 14, 2021
Prevalence and Clinical Characteristics of Hidradenitis Suppurativa Phenotypes in a Large Dutch CohortKoen Dudink, Pim Aarts, Christine B Ardon, et al.
Journal of the American Academy of Dermatology|August 9, 2020
Impact of hidradenitis suppurativa on work productivity and associated risk factorsKelsey R van Straalen, Lisette M Prens, Tjerk H Hylkema, et al.
Pageof 18